WALTHAM, Mass.--(BUSINESS WIRE)--Nov 8, 2023--Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biopharmaceutical company focused on discovering and developing potential best-in-class medicines for serious and rare diseases, today announced that senior management will participate in a fireside chat ...
NEW YORK--(BUSINESS WIRE)--Nov 8, 2023--<a ...
NEW HAVEN, Conn.--(BUSINESS WIRE)--Nov 8, 2023--Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced its participation in ...
CHICAGO & IRVINE, Calif.--(BUSINESS WIRE)--Nov 8, 2023--<a ...
DUBLIN--(BUSINESS WIRE)--Nov 8, 2023--The <a ...
SAN FRANCISCO--(BUSINESS WIRE)--Nov 8, 2023--<a ...
